Literature DB >> 19051021

Diminution of Circulating CD4+CD25 high T cells in naïve Crohn's disease.

Patrick Chamouard1, Fanny Monneaux, Zoe Richert, Anne-Claire Voegeli, Thomas Lavaux, Marie Pierre Gaub, René Baumann, Pierre Oudet, Sylviane Muller.   

Abstract

Crohn's disease is considered to be caused either by an excess of T-cell effector functions and/or by a defective regulatory T-cell compartment. The aim of this study was to assess in Crohn's disease the frequency of circulating CD4(+)CD25(high) T cells that possess regulatory T-cell functions and CD4(+)CD25(low) T cells that contain activated T cells. Flow cytometry of peripheral blood was used to assess CD4(+)CD25(high) and CD4(+)CD25(low) T-cell frequencies in a cohort of 66 patients with Crohn's disease in comparison to 19 patients with ulcerative colitis and 31 healthy individuals enrolled as controls. The CD4(+)CD25(high) T-cell frequency was significantly lowered in naïve Crohn's disease (P = 0.013) and in ulcerative colitis (P = 0.001). CD4(+)CD25(low) T-cell frequency was increased in Crohn's disease (P = 0.0001) and in ulcerative colitis (P = 0.0002). Both CD4(+)CD25(high) and CD4(+)CD25(low) T-cell frequencies are altered in naïve Crohn's disease resulting in an imbalance between both populations and a relative contraction of the CD4(+)CD25(high) T-cell population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19051021     DOI: 10.1007/s10620-008-0590-6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  33 in total

Review 1.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

2.  Control freaks: immune regulatory cells.

Authors:  Cathryn Nagler-Anderson; Atul K Bhan; Daniel K Podolsky; Cox Terhorst
Journal:  Nat Immunol       Date:  2004-02       Impact factor: 25.606

3.  NOD2/CARD15 gene polymorphisms in Crohn's disease: a genotype- phenotype analysis.

Authors:  Denis Heresbach; Véronique Gicquel-Douabin; Brigitte Birebent; Pierre-Nicolas D'halluin; Nathalie Heresbach-Le Berre; Stéphane Dreano; Laurent Siproudhis; Alain Dabadie; Michel Gosselin; Jean Mosser; Gilbert Semana; Jean-François Bretagne; Jacqueline Yaouanq
Journal:  Eur J Gastroenterol Hepatol       Date:  2004-01       Impact factor: 2.566

4.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

Authors:  Mark S Silverberg; Jack Satsangi; Tariq Ahmad; Ian D R Arnott; Charles N Bernstein; Steven R Brant; Renzo Caprilli; Jean-Frédéric Colombel; Christoph Gasche; Karel Geboes; Derek P Jewell; Amir Karban; Edward V Loftus; A Salvador Peña; Robert H Riddell; David B Sachar; Stefan Schreiber; A Hillary Steinhart; Stephan R Targan; Severine Vermeire; B F Warren
Journal:  Can J Gastroenterol       Date:  2005-09       Impact factor: 3.522

Review 5.  Signalling pathways and molecular interactions of NOD1 and NOD2.

Authors:  Warren Strober; Peter J Murray; Atsushi Kitani; Tomohiro Watanabe
Journal:  Nat Rev Immunol       Date:  2006-01       Impact factor: 53.106

Review 6.  Oral tolerance.

Authors:  W Strober; B Kelsall; T Marth
Journal:  J Clin Immunol       Date:  1998-01       Impact factor: 8.317

7.  Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis.

Authors:  Duojia Cao; Vivianne Malmström; Clare Baecher-Allan; David Hafler; Lars Klareskog; Christina Trollmo
Journal:  Eur J Immunol       Date:  2003-01       Impact factor: 5.532

8.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

9.  NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses.

Authors:  Tomohiro Watanabe; Atsushi Kitani; Peter J Murray; Warren Strober
Journal:  Nat Immunol       Date:  2004-06-27       Impact factor: 25.606

10.  Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.

Authors:  F Powrie; R Correa-Oliveira; S Mauze; R L Coffman
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states.

Authors:  Maria Serena Longhi; Simon C Robson; Steven H Bernstein; Sara Serra; Silvia Deaglio
Journal:  J Mol Med (Berl)       Date:  2013-01-06       Impact factor: 4.599

Review 2.  Old and New Lymphocyte Players in Inflammatory Bowel Disease.

Authors:  Paolo Giuffrida; Gino Roberto Corazza; Antonio Di Sabatino
Journal:  Dig Dis Sci       Date:  2017-12-23       Impact factor: 3.199

3.  Immune phenotype in children with therapy-naïve remitted and relapsed Crohn's disease.

Authors:  Aron Cseh; Barna Vasarhelyi; Kriszta Molnar; Balazs Szalay; Peter Svec; Andras Treszl; Antal Dezsofi; Peter-Laszlo Lakatos; Andras Arato; Tivadar Tulassay; Gabor Veres
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

4.  Infliximab therapy impacts the peripheral immune system of immunomodulator and corticosteroid naïve patients with Crohn's disease.

Authors:  Kyoichi Kato; Ken Fukunaga; Koji Kamikozuru; Shinichiro Kashiwamura; Nobuyuki Hida; Yoshio Ohda; Naohisa Takeda; Koji Yoshida; Masaki Iimuro; Yoko Yokoyama; Risa Kikuyama; Hiroto Miwa; Takayuki Matsumoto
Journal:  Gut Liver       Date:  2011-03-16       Impact factor: 4.519

5.  Colitis and intestinal inflammation in IL10-/- mice results from IL-13Rα2-mediated attenuation of IL-13 activity.

Authors:  Mark S Wilson; Thirumalai R Ramalingam; Aymeric Rivollier; Kevin Shenderov; Margaret M Mentink-Kane; Satish K Madala; Allen W Cheever; David Artis; Brian L Kelsall; Thomas A Wynn
Journal:  Gastroenterology       Date:  2010-10-14       Impact factor: 22.682

Review 6.  Helicobacter pylori: Does Gastritis Prevent Colitis?

Authors:  Isabelle C Arnold; Anne Müller
Journal:  Inflamm Intest Dis       Date:  2016-05-13

7.  Characterization of human CD39+ Th17 cells with suppressor activity and modulation in inflammatory bowel disease.

Authors:  Maria Serena Longhi; Alan Moss; Aiping Bai; Yan Wu; Huang Huang; Adam Cheifetz; Francisco J Quintana; Simon C Robson
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

Review 8.  The Immunological Basis of Inflammatory Bowel Disease.

Authors:  Francesca A R Silva; Bruno L Rodrigues; Maria de Lourdes S Ayrizono; Raquel F Leal
Journal:  Gastroenterol Res Pract       Date:  2016-12-14       Impact factor: 2.260

9.  IL-1β promotes Th17 differentiation by inducing alternative splicing of FOXP3.

Authors:  Reiner K W Mailer; Anne-Laure Joly; Sang Liu; Szabolcs Elias; Jesper Tegner; John Andersson
Journal:  Sci Rep       Date:  2015-10-06       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.